TY - JOUR
T1 - Clinical Significance of Shared T Cell Epitope Analysis in Early De Novo Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope Analysis
AU - Tomosugi, Toshihide
AU - Iwasaki, Kenta
AU - Sakamoto, Shintaro
AU - Niemann, Matthias
AU - Spierings, Eric
AU - Nahara, Isao
AU - Futamura, Kenta
AU - Okada, Manabu
AU - Hiramitsu, Takahisa
AU - Takeda, Asami
AU - Goto, Norihiko
AU - Narumi, Shunji
AU - Watarai, Yoshihiko
AU - Kobayashi, Takaaki
N1 - Funding Information:
The authors thank Harue Fukami and Kohei Nishida of the Histocompatibility Laboratory at Nagoya Red Cross Hospital for their excellent technical assistance.
Funding Information:
This work was supported by JSPS KAKENHI Grant Numbers 20H03818 and 20K20608.
Publisher Copyright:
© Copyright © 2021 Tomosugi, Iwasaki, Sakamoto, Niemann, Spierings, Nahara, Futamura, Okada, Hiramitsu, Takeda, Goto, Narumi, Watarai and Kobayashi.
PY - 2021/3/26
Y1 - 2021/3/26
N2 - In pre-sensitizing events, immunological memory is mainly created via indirect allorecognition where CD4+ T cells recognize foreign peptides in the context of self-HLA class II (pHLA) presented on antigen-presenting cells. This recognition makes it possible for naive CD4+ T-helper cells to differentiate into memory cells, resulting in the creation of further antibody memory. These responses contribute to effective secretion of donor-specific anti-HLA antibodies (DSA) after second encounters with the same peptide. Preformed donor-reactive CD4+ memory T cells may induce early immune responses after transplantation; however, the tools to evaluate them are limited. This study evaluated shared T cell epitopes (TEs) between the pre-sensitizing and donor HLA using an in silico assay, an alternative to estimate donor-reactive CD4+ memory T cells before transplantation. In 578 living donor kidney transplants without preformed DSA, 69 patients had anti-HLA antibodies before transplantation. Of them, 40 had shared TEs and were estimated to have donor-reactive CD4+ memory T cells. De novo DSA formation in the early phase was significantly higher in the shared TE-positive group than in the anti-HLA antibody- and shared TE-negative groups (p=0.001 and p=0.02, respectively). In conclusion, evaluation of shared TEs for estimating preformed donor-reactive CD4+ memory T cells may help predict the risk of early de novo DSA formation after kidney transplantation.
AB - In pre-sensitizing events, immunological memory is mainly created via indirect allorecognition where CD4+ T cells recognize foreign peptides in the context of self-HLA class II (pHLA) presented on antigen-presenting cells. This recognition makes it possible for naive CD4+ T-helper cells to differentiate into memory cells, resulting in the creation of further antibody memory. These responses contribute to effective secretion of donor-specific anti-HLA antibodies (DSA) after second encounters with the same peptide. Preformed donor-reactive CD4+ memory T cells may induce early immune responses after transplantation; however, the tools to evaluate them are limited. This study evaluated shared T cell epitopes (TEs) between the pre-sensitizing and donor HLA using an in silico assay, an alternative to estimate donor-reactive CD4+ memory T cells before transplantation. In 578 living donor kidney transplants without preformed DSA, 69 patients had anti-HLA antibodies before transplantation. Of them, 40 had shared TEs and were estimated to have donor-reactive CD4+ memory T cells. De novo DSA formation in the early phase was significantly higher in the shared TE-positive group than in the anti-HLA antibody- and shared TE-negative groups (p=0.001 and p=0.02, respectively). In conclusion, evaluation of shared TEs for estimating preformed donor-reactive CD4+ memory T cells may help predict the risk of early de novo DSA formation after kidney transplantation.
KW - B cell epitope analysis
KW - donor-specific antibody
KW - kidney transplantation
KW - PIRCHE-II
KW - T cell epitope analysis
UR - http://www.scopus.com/inward/record.url?scp=85104575081&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.621138
DO - 10.3389/fimmu.2021.621138
M3 - Article
C2 - 33897684
SN - 1664-3224
VL - 12
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 621138
ER -